Sarcoidosis in the Middle East
- PMID: 31007761
- PMCID: PMC6467024
- DOI: 10.4103/atm.ATM_227_18
Sarcoidosis in the Middle East
Abstract
Sarcoidosis, a systemic granulomatous disease of unknown cause, has been described worldwide and in all populations with notable differences in clinical characteristics, organ involvement, disease severity, and prognosis among different ethnic and racial groups. While the exact prevalence of sarcoidosis in the Middle East is unknown, studies from various countries in the region have reported the clinical characteristics of affected patients, along with a few anecdotal reports. A search of the MEDLINE and Google Scholar databases was conducted for relevant English-language articles using the terms "sarcoidosis" and "Middle East" or "sarcoidosis" and "Arabs." Subsequently, the names of individual countries were used as search terms, replacing "Middle East." Overall, the clinical picture of patients with sarcoidosis in the Middle East is similar to that reported elsewhere; for example, the disease was more frequent among females and respiratory complaints were the predominant symptoms. Within the region, most patients from Oman were older and female, with arthralgia, hypercalcemia, and eye involvement being more common. Constitutional symptoms were frequent, especially among patients from Iran. Cough was more common among patients from Kuwait and Iran, while dyspnea was the predominant symptom for Saudi patients. Erythema nodosum was more common in the Turkish population. Clustering was seen in patients with Stage I and II of the disease in all countries except Oman. Apart from those in Iran, the prognosis of most patients from the Middle East was excellent.
Keywords: Arabs; Middle East; sarcoidosis.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Clinical features of Sarcoidosis in Oman: A report from the Middle East region.Sarcoidosis Vasc Diffuse Lung Dis. 2016 Oct 7;33(3):201-208. Sarcoidosis Vasc Diffuse Lung Dis. 2016. PMID: 27758984
-
Clinical presentation of sarcoidosis in a mixed population in the middle east.Respir Med. 2007 Nov;101(11):2284-8. doi: 10.1016/j.rmed.2007.06.025. Epub 2007 Aug 13. Respir Med. 2007. PMID: 17697768
-
Sarcoidosis in Arabs: the clinical profile of 20 patients and review of the literature.Sarcoidosis. 1991 Mar;8(1):56-62. Sarcoidosis. 1991. PMID: 1669942
-
The prevalence of asthma and related symptoms in Middle East countries.Clin Respir J. 2018 Mar;12(3):865-877. doi: 10.1111/crj.12655. Epub 2017 Jun 12. Clin Respir J. 2018. PMID: 28544458 Review.
-
Joint involvement in sarcoidosis: systematic review and meta-analysis of prevalence, clinical pattern and outcome.Rheumatology (Oxford). 2024 Jul 1;63(7):1803-1814. doi: 10.1093/rheumatology/keae048. Rheumatology (Oxford). 2024. PMID: 38281070
Cited by
-
Elderly sarcoidosis in Japan.J Int Med Res. 2022 Dec;50(12):3000605221142705. doi: 10.1177/03000605221142705. J Int Med Res. 2022. PMID: 36562117 Free PMC article.
-
The evaluation of interleukin-4 and interleukin-13 in the serum of pulmonary sarcoidosis and tuberculosis patients.J Res Med Sci. 2020 Mar 18;25:24. doi: 10.4103/jrms.JRMS_74_19. eCollection 2020. J Res Med Sci. 2020. PMID: 32419781 Free PMC article.
-
First insights and future research perspectives from the sarcoidosis registry at the Medical University of Vienna.Sci Rep. 2025 Mar 13;15(1):8644. doi: 10.1038/s41598-025-93708-9. Sci Rep. 2025. PMID: 40082706 Free PMC article.
References
-
- Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Müller-Quernheim J, et al. Sarcoidosis. Lancet. 2014;383:1155–67. - PubMed
-
- Wilsher ML. Seasonal clustering of sarcoidosis presenting with erythema nodosum. Eur Respir J. 1998;12:1197–9. - PubMed
-
- Chen ES, Moller DR. Etiology of sarcoidosis. Clin Chest Med. 2008;29:365–77, vii. - PubMed